View:
Download DOC
Download PDF
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Kawwas Charlie B
(Last) (First) (Middle)
C/O AVAGO TECHNOLOGIES U.S. INC.
1320 RIDDER PARK DRIVE
(Street)
SAN JOSE CA 95131
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/03/2015 		3. Issuer Name and Ticker or Trading Symbol
Avago Technologies LTD [ AVGO ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP WORLDWIDE SALES
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 73,742(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Based Restricted Stock Units (2) (3) Ordinary Shares 15,000 0.0 D
Stock Option (Right to Buy) (4) 03/01/2021 Ordinary Shares 8,494 62.63 D
Stock Option (Right to Buy) (5) 03/01/2020 Ordinary Shares 7,337 38.92 D
Stock Option (Right to Buy) (6) 03/01/2019 Ordinary Shares 3,879 48.18 D
Stock Option (Right to Buy) (7) 06/09/2021 Ordinary Shares 120,000 71.86 D
Explanation of Responses:
1. Includes 73,742 Restricted Stock Units.
2. Share price performance RSU (the "Performance RSU") granted pursuant to the Avago Technologies Limited 2009 Equity Incentive Award Plan (the "Avago Plan"). The Performance RSU vests over four years, with 25% vesting on each anniversary of the date of grant. However, no portion of the Performance RSU shall vest unless and until the average of the closing prices of the Company's ordinary shares (as reported on the stock exchange on which the shares are listed), over a twenty consecutive trading day period is equal to or greater than 120% of the fair market value of the Company's ordinary shares on the date of grant (the "Price Contingency").
3. In the event the Price Contingency is not met on or before the fourth anniversary of the grant date, March 15, 2015, or the Reporting Person's termination of services in the Company, all Performance RSUs subject to the award which have not previously vested shall immediately be forfeited.
4. Option to purchase ordinary shares of the Company, granted pursuant to the LSI Corporation 2003 Equity Incentive Plan, assumed by the Company upon the closing of its acquisition of LSI on May 6, 2014 (the "LSI Plan"). The option vests over 4 years, with one-fourth vesting on March 1 of each of 2015, 2016, 2017, 2018, subject to the Reporting Person's continuing service on each vesting date.
5. Option to purchase ordinary shares of the Company, granted pursuant to the LSI Plan. The option vests over 3 years, with one-third vesting on March 1 of each of 2015, 2016, 2017, subject to the Reporting Person's continuing service on each vesting date.
6. Option to purchase ordinary shares of the Company, granted pursuant to the LSI Plan. The option vests over 2 years, with 50% vesting on March 1, 2015 and 50% vesting on March 1, 2016, subject to the Reporting Person's continuing service on each vesting date.
7. Share price performance option (the "Performance Option") granted pursuant to the Avago Plan. The Performance Option vests over four years, with 25% vesting on each anniversary of the date of grant. The Performance Option will not become exercisable until the date on which the average of the closing prices of the Company's ordinary shares (as reported on the stock exchange on which the shares are listed), over a ten consecutive trading day period is equal to or greater than 120% of the exercise price of Performance Option.
Remarks:
EXHIBIT LIST: EX-24 POA Kawwas 2015.06
/s/ Patricia McCall, Attorney-in-Fact for Charlie B Kawwas 06/09/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of (i) the Chief Financial Officer of Avago Technologies Limited, a limited company organized under the laws of the Republic of Singapore (the "Company") and who is currently Anthony E. Maslowski (Chief Financial Officer), (ii) the Company's General Counsel, who is currently Patricia H. McCall, (iii) the Company's Vice President, Human Resources, who is currently Debbie Streeter, and (iv) the Company's Associate General Counsel, Corporate & Securities, who is currently Rebecca Boyden, and their respective successors (including anyone serving in such capacities on an interim or acting basis), signing singly, with full powers of substitution, as the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer of the Company, Forms3, 4 and 5 (including amendments thereto) in accordance with Section16(a) of the Securities Exchange Act of 1934 and the rules and regulations thereunder and a Form ID, Uniform Application for Access Codes to File on EDGAR;
(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms 3, 4 or 5 or Form ID (including amendments thereto) and timely file such forms (including amendments thereto) and application with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section16 of the Securities Exchange Act of 1934.

The undersigned agrees that each such attorney-in-fact herein may rely entirely on information furnished orally or in writing by the undersigned to such attorney-in-fact.  The undersigned also agrees to indemnify and hold harmless the Company and each such attorney-in-fact against any losses, claims, damages or liabilities (or actions in these respects) that arise out of or are based upon any untrue statements or omission of necessary facts in the information provided by the undersigned to such attorney-in fact for purposes of executing, acknowledging, delivering or filing Forms 3, 4 or 5 (including amendments thereto) or Form ID and agrees to reimburse the Company and such attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, damage, liability or action.

This Power of Attorney supersedes any power of attorney previously executed by the undersigned regarding the purposes outlined in the first paragraph hereof ("Prior Powers of Attorney"), and the authority of the attorneys-in-fact named in any Prior Powers of Attorney is hereby revoked.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms3, 4 or 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier (a)revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or (b)superseded by a new power of attorney regarding the purposes outlined in the first paragraph hereof dated as of a later date.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 9 day of June, 2015.

Charlie B. Kawwas